Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

计划入组 597 人 · 首次发布于 2008 年 3 月 12 日

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

计划入组 21 人 · 首次发布于 2020 年 3 月 17 日

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

计划入组 147 人 · 首次发布于 2023 年 10 月 25 日

Multiple Electrolytes

Rx

Other immune cell types(Notch)

multiple myeloma therapy

Stiftung Swiss Tumor Institute

Switzerland

Multiple Myeloma Research Consortium

United States

National Multiple Sclerosis Society

United States

Fecal Microbiota Transplantation Shows Promise in Enhancing Cancer Immunotherapy Across Multiple Tumor Types

Mount Sinai's Personalized Cancer Vaccine PGV001 Shows Promise Across Multiple Tumor Types in Phase 1 Trial

STC-15, a Novel METTL3 Inhibitor, Shows Clinical Promise Across Multiple Tumor Types in Phase 1 Trial